Parkinsonian signs in subjects with mild cognitive impairment

Neurology

Volumn 65, Issue 12, 2005, Pages 1901-1906

  Boyle, P A ^a,b   Wilson, R S ^a,b   Aggarwal, N T ^a,b   Arvanitakis, Z ^a,b   Kelly, J ^a,b   Bienias, J L ^b,c   Bennett, D A ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BRADYKINESIA; CLINICAL EXAMINATION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GAIT DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSONISM; PRIORITY JOURNAL; RIGIDITY; RISK FACTOR; TREMOR; VASCULAR DISEASE; BRAIN ARTERY; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMORBIDITY; EPIDEMIOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; MULTIINFARCT DEMENTIA; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; UNITED STATES;

AGED; AGED, 80 AND OVER; CAUSALITY; CEREBRAL ARTERIES; CEREBROVASCULAR DISORDERS; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; DEMENTIA, VASCULAR; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PARKINSONIAN DISORDERS; RISK FACTORS; UNITED STATES;

EID: 33645747724     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000188878.81385.73     Document Type: Article

References (51)

1. Bennett DA, Beckett LA, Murray AM, et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 1996;334:71-76.
2. Louis ED, Tang MX, Schupf N, Mayeux R. Functional correlates and prevalence of mild parkinsonian signs in a community population of older people. Arch Neurol 2005;62:297-302.
3. Richards M, Stern Y, Mayeux R. Subtle extrapyramidal signs can predict the development of dementia in elderly individuals. Neurology 1993;43:2184-2188.
4. Louis ED, Tang MX, Mayeux R. Parkinsonian signs in older people in a community-based study: risk of incident dementia. Arch Neurol 2004;61:1273-1276.
5. Wilson RS, Schneider JA, Beckett LA, Evans DA, Bennett DA. Progression of gait disorder and rigidity and risk of death in older persons. Neurology 2002;58:1815-1819.
6. Richards M, Bell K, Dooneief G, et al. Patterns of neuropsychological test performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology 1993;43:1708-1711.
7. Scarmeas N, Hadjigeorgiou GM, Papadimitriou A, et al. Motor signs during the course of Alzheimer disease. Neurology 2004;63:975-982.
8. Wilson RS, Bennett DA, Gilley DW, Beckett LA, Schneider JA, Evans DA. Progression of parkinsonism and loss of cognitive function in Alzheimer's disease. Arch Neurol 2000;57:855-860.
9. Mitchell SL, Rockwood K. The association between parkinsonism, Alzheimer's disease, and mortality: a comprehensive approach. JAGS 2000;48:422-425.
10. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-1142.
11. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005;64:834-841.
12. Morris JC, Price AL. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J Mol Neurosci 2001;17:101-118.
13. Louis ED, Schupf N, Manly J, Marder K, Tang MX, Mayeux R. Association between mild parkinsonian signs and mild cognitive impairment in a community. Neurology 2005;64:1157-1161.
14. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon C, Bienias JL, Wilson RS. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 2005; 25:163-175.
15. Wilson RS, Barnes LL, Bennett DA. Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Psychol 2003;25:634-642.
16. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Standlan E. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
17. Bennett DA, Wilson RS, Schneider JA, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;59:198-205.
18. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry (in press).
19. Folstein M, Folstein S, McHugh P. Mini-Mental State: a practical method for grading the mental state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
20. Bennett DA, Shannon KM, Beckett LA, Goetz CG, Wilson RS. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 1997;49:1580-1586.
21. Bennett DA, Shannon KM, Beckett LA, Wilson RS. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J Gerontol A Biol Sci Med Sci 1999;54A:M191-196.
22. Fahn S, Elton R. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden C, Goldstein M, Calne D, eds. Recent developments in Parkinson's disease, vol. 12. Florham Park, NJ: MacMillan Healthcare Information, 1987;153-163.
23. Fleischman DA, Wilson RS, Bienias JL, Bennett DA. Parkinsonian signs and cognitive function in old age. JINS 2005;11:591-597.
24. Wechsler D. Wechsler Memory Scale-Revised manual. San Antonio, TX: Psychological Corporation, 1987.
25. Albert M, Smith L, Scherr P, Taylor J, Evans D, Funkenstein H. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-178.
26. Wilson RS, Beckett LA, Barnes LL, et al. Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179-193.
27. Morris J, Heyman A, Mohs R, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1165.
28. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
29. Cooper JA, Sagar HJ. Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713-731.
30. Smith A. Symbol Digit Modalities Test manual-revised. Los Angeles: Western Psychological Services, 1992.
31. Ekstrom RB, French JW, Harman HH, Kermen D. Manual for kit of factor-referenced cognitive tests. Princeton, NJ: Educational Testing Service, 1976.
32. Trenerry MR, Crosson B, DeBoe J, Leber WR. The Stroop Neuropsychological Screening Test. Odessa, FL: Psychological Assessment Resources, 1989.
33. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment (2nd ed). New York: Oxford University Press, 1994.
34. Raven JC, Court JH, Raven J. Manual for Raven's progressive matrices and vocabulary: Standard Progressive Matrices. Oxford: Oxford Psychologists Press, 1992.
35. Goodglass H, Kaplan E. The assessment of aphasia and related disorders. Philadelphia: Lea & Febiger, 1972.
36. Wilson RS, Barnes LL, Krueger KR, Hoganson G, Bienias JL, Bennett DA. Early and late-life cognitive activity and cognitive systems in old age. JINS (in press).
37. Medi-Span. Master drug data base documentation manual. Indianapolis, IN: Medi-Span, 1995.
38. Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA. Hallucinations, delusions, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2000;69:172-177.
39. Schneider JA, Bienias JL, Wilson RS, Berry-Kravis E, Evans DA, Bennett DA. The apolipoprotein E4 allele increases the odds of chronic cerebral infarction detected at autopsy in older persons. Stroke 2005;36:954-959.
40. SAS Institute Inc. SAS/STAT User's Guide, version 8. Cary, NC: SAS Institute Inc., 2000.
41. Waite LM, Grayson DA, Piguet O, Creasey H, Bennett HP, Broe GA. Gait slowing as a predictor of incident dementia: 6-year longitudinal data from the Sydney Older Persons Study. J Neurol Sci 2005;229-230:89-93.
42. Egner T, Hirsch J. The neural correlates and functional integration of cognitive control in a Stroop task. Neuroimage 2005;24:539-547.
43. Kassubek J, Juengling FD, Ecker D, Landwehrmeyer GB. Thalamic atrophy in Huntington's disease co-varies with cognitive performance: a morphometric MRI analysis. Cerebral Cortex 2005;6:846-853.
44. Liu Y, Stern Y, Chun M, Jacobs D, Yau P, Goldman J. Pathological correlates of extrapyramidal signs in Alzheimer's disease. Ann Neurol 1997;41:368-374.
45. Hulette C, Mirra S, Wilkinson W, Heyman A, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Part IX: A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease. Neurology 1995;45:1991-1995.
46. Ditter S, Mirra S. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease. Neurology 1987;37:754-760.
47. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001;2:63-67.
48. Haan MN, Jagust WJ, Galasko D, Kaye J. Effect of extrapyramidal signs and Lewy bodies on survival in patients with Alzheimer disease. Arch Neurol 2002;59:588-593.
49. Price TR, Manolio TA, Kronmal RA, et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The Cardiovascular Health Study. Stroke 1997;28:1158-1164.
50. Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 1995;37:300-312.
51. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol 2002;51:567-577.